SAIBR

SAIBR performs regression-based spectral autofluorescence correction to enable accurate quantification of fluorescent proteins such as GFP and mNeonGreen in imaging of endogenously tagged proteins (e.g., via CRISPR/Cas9).


Key Features:

  • Regression-based correction: Uses regression to model and remove autofluorescence contributions from spectral image data.
  • Standard filter sets and illumination: Operates using standard filter sets and illumination conditions for spectral measurements.
  • Platform independence: Applies across different microscopy setups without reliance on specialized hardware.
  • Enhanced signal quantification: Improves detection and accurate quantitation of weak fluorophore signals obscured by autofluorescence.
  • Validation across model systems: Has been validated in C. elegans embryos, starfish oocytes, and fission yeast.

Scientific Applications:

  • Quantitative endogenous protein measurement: Enables accurate measurement of protein expression from endogenously tagged genes, including low-expression targets.
  • Fluorescent protein imaging: Improves signal separation and quantitation for GFP and mNeonGreen where emission overlaps with tissue autofluorescence.
  • Developmental and cell biology imaging: Facilitates fluorescence-based assays in embryos, oocytes, and yeast by reducing autofluorescence interference.
  • CRISPR/Cas9-based tagging studies: Supports imaging studies that rely on endogenous fluorescent tagging to monitor proteins under native regulation.

Methodology:

Performs spectral autofluorescence correction by regression using measurements from standard filter sets and illumination conditions.

Topics

Details

License:
CC-BY-4.0
Cost:
Free of charge
Tool Type:
plugin
Operating Systems:
Mac, Linux, Windows
Programming Languages:
Java
Added:
9/17/2022
Last Updated:
11/24/2024

Operations

Publications

Rodrigues NTL, Bland T, Borrego-Pinto J, Ng K, Hirani N, Gu Y, Foo S, Goehring NW. SAIBR: a simple, platform-independent method for spectral autofluorescence correction. Development. 2022;149(14). doi:10.1242/dev.200545. PMID:35713287. PMCID:PMC9445497.

PMID: 35713287
PMCID: PMC9445497
Funding: - Cancer Research UK: FC001086 - Medical Research Council: FC001086 - Wellcome Trust: 220790/Z/20/Z, FC001086 - Biotechnology and Biological Sciences Research Council: BB/T000481/1

Documentation

Related Tools

imagej
Relation: uses